Neko Health raises 200m SEK in new funding round
Healthtech firm Neko Health, led by CEO Hjalmar Nilsonne, has secured a further major funding round of 200 million SEK.
What happened?
Neko Health has secured 200 million SEK in a new funding round. The company is now valued at approximately 1.2 billion SEK, following total capital injections of 300 million SEK. This investment establishes Neko Health as one of Sweden's highest-valued tech companies within the healthcare sector.
Key facts
| Finansieringsbelopp | 200 MSEK |
|---|---|
| Totalt insamlat kapital | 300 MSEK |
| Antal skanningar hittills | Över 100 000 |
| Värdering (post-money) | Ca 1,2 miljarder SEK |
| Målsättning | Nå miljontals användare |
”Det finns möjlighet att bli ett av världens viktigaste företag.”
Why it matters
The new financing enables Neko Health to continue expanding and developing its body scanning technologies. The goal is to scale from over 100,000 scans to millions, potentially reshaping preventative healthcare through early disease detection. The significant investment confirms market confidence in the company's business model.
Who is affected?
The funding round primarily impacts Neko Health's management, employees, and investors. Developers in medtech and AI may also be affected by increased competition and innovation in the field. Users of Neko Health's services in Sweden and other expansion markets will gain access to their preventative health screenings.
Impact on the EU
Founded in Sweden, Neko Health is available within the EU. Its expansion and growth enable more EU citizens to access its preventative healthcare services. Crucially for its EU status, medical technology products and services in the EEA must comply with strict EU regulations, including the Medical Device Regulation (MDR) and GDPR for data protection.
What else you should know
The founders are Hjalmar Nilsonne and Daniel Ek.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Vilka bolag berörs?
The link opens in a new window and leads to the publisher's own site.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.
AI-verktyg i artikeln
Topics
Get similar news straight to your inbox
The reader's room
Send in a question or an addition. The newsroom reads everything before it's published and replies when relevant. No AI-generated text – just people.
Sign in to submit a comment or question.
Read the article through your role
- Where does a window open: market, tech, distribution or pricing?
- What can you test in under two weeks without burning capital?
- Who do you need to talk to this week to validate the assumption?
Generated angle — not editorial analysis of "Neko Health raises 200m SEK in new funding round"